Skip to main content
Premium Trial:

Request an Annual Quote

Where Does the Data Go?

Data from scientific studies are quickly lost to time, according to a report appearing in Current Biology.

A group of researchers in Canada examined 516 articles published between 1991 and 2011, and "found that availability of the data was strongly affected by article age." For instance, the team reports that the odds of finding a working email address associated with a paper decreased by 7 percent each year and that the odds of an extant dataset decreased by 17 percent each year since publication. Some data was technically available, the researchers note, but stored on floppy disk or on zip drives that many researchers no longer have the hardware to access.

"I don't think anybody expects to easily obtain data from a 50-year-old paper, but to find that almost all the datasets are gone at 20 years was a bit of a surprise," first author Tim Vines from the University of British Columbia said in a statement.

Vines also says that journals should require depositions as a condition of publication and that papers with accessible data should get priority for publication.

"Losing data is a waste of research funds and it limits how we can do science," Vines adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.